|
pain
|
SYMP_0000099 |
[A sensation perception where there is an unpleasant sensation that usually indicates the body is threatened or damaged. The sensation may be sharp or dull, short-lived or chronic, intermittent or continual, confined to one area or spread over the entire body.] |
|
Hepatitis
|
HP_0012115 |
[Inflammation of the liver.] |
|
Abnormal liver morphology
|
HP_0410042 |
[Any structural anomaly of the bile-secreting organ that is important for detoxification, for fat, carbohydrate, and protein metabolism, and for glycogen storage.] |
|
Ile(5)-angiotensin II (1-7)
|
CHEBI_55438 |
[An angiotensin compound consisting of the linear heptapeptide sequence L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro.] |
|
ribonucleoside monophosphate metabolic process
|
GO_0009161 |
[The chemical reactions and pathways involving a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.] |
|
nucleoside monophosphate metabolic process
|
GO_0009123 |
[The chemical reactions and pathways involving a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar.] |
|
regulation of mitotic cell cycle phase transition
|
GO_1901990 |
[Any process that modulates the frequency, rate or extent of mitotic cell cycle phase transition.] |
|
purine ribonucleoside monophosphate metabolic process
|
GO_0009167 |
[The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.] |
|
purine nucleoside monophosphate metabolic process
|
GO_0009126 |
[The chemical reactions and pathways involving purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.] |
|
negative regulation of mitotic cell cycle phase transition
|
GO_1901991 |
[Any process that stops, prevents or reduces the frequency, rate or extent of mitotic cell cycle phase transition.] |
|
purine ribonucleoside monophosphate biosynthetic process
|
GO_0009168 |
[The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.] |
|
purine nucleoside monophosphate biosynthetic process
|
GO_0009127 |
[The chemical reactions and pathways resulting in the formation of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.] |
|
fosamprenavir
|
CHEBI_82941 |
[A sulfonamide with a structure based on that of sulfanilamide substituted on the sulfonamide nitrogen by a (2R,3S)-4-phenyl-2-(phosphonooxy)-3-({[(3S)-tetrahydrofuran-3-yloxy]carbonyl}amino)butyl group. It is a pro-drug of the HIV protease inhibitor and antiretroviral drug amprenavir.] |
|
positive regulation of mitotic cell cycle phase transition
|
GO_1901992 |
[Any process that activates or increases the frequency, rate or extent of mitotic cell cycle phase transition.] |
|
positive regulation of mitotic cell cycle
|
GO_0045931 |
[Any process that activates or increases the rate or extent of progression through the mitotic cell cycle.] |
|
nucleoside phosphate biosynthetic process
|
GO_1901293 |
[The chemical reactions and pathways resulting in the formation of a nucleoside phosphate.] |
|
Ranitidine bismuth citrate
|
CHEBI_77596 |
[Complex of ranitidine, trivalent bismuth, and citrate. CAS#128345-62-0.] |
|
Pandemics
|
OMIT_0027404 |
|
|
nelfinavir
|
CHEBI_7496 |
[An aryl sulfide that is used (as its mesylate salt) for treatment of HIV and also exhibits some anticancer properties.] |
|
ALPL
|
OGG_3000000249 |
|